These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9558128)

  • 1. Valproate as monotherapy for juvenile myoclonic epilepsy: dose-effect study.
    Sundqvist A; Tomson T; Lundkvist B
    Ther Drug Monit; 1998 Apr; 20(2):149-57. PubMed ID: 9558128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
    Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate monotherapy in juvenile myoclonic epilepsy: dose-related effects on electroencephalographic and other neurophysiologic tests.
    Sundqvist A; Nilsson BY; Tomson T
    Ther Drug Monit; 1999 Feb; 21(1):91-6. PubMed ID: 10051060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of juvenile myoclonic epilepsy with low-dose sodium valproate].
    De Toffol B; Autret A
    Rev Neurol (Paris); 1996 Nov; 152(11):708-10. PubMed ID: 9033947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
    Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of lamotrigine in juvenile myoclonic epilepsy.
    Buchanan N
    Seizure; 1996 Jun; 5(2):149-51. PubMed ID: 8795132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile myoclonic epilepsy: diagnosis, management and outcome.
    Sharpe C; Buchanan N
    Med J Aust; 1995 Feb; 162(3):133-4. PubMed ID: 7854224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy.
    Sundqvist A; Tomson T; Lundkvist B
    Ther Drug Monit; 1997 Apr; 19(2):153-9. PubMed ID: 9108642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
    Gürer R; Aydın Ş; Özkara Ç
    Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy with valproate in primary generalized epilepsies.
    Bourgeois B; Beaumanoir A; Blajev B; de la Cruz N; Despland PA; Egli M; Geudelin B; Kaspar U; Ketz E; Kronauer C
    Epilepsia; 1987; 28 Suppl 2():S8-11. PubMed ID: 3121293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
    Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
    Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile myoclonic epilepsy: long-term response to therapy.
    Penry JK; Dean JC; Riela AR
    Epilepsia; 1989; 30 Suppl 4():S19-23; discussion S24-7. PubMed ID: 2506007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of valproate across the ages. Treatment of epilepsy in children.
    Aldenkamp A; Vigevano F; Arzimanoglou A; Covanis A
    Acta Neurol Scand Suppl; 2006; 184():1-13. PubMed ID: 16776492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical-epidemiological study of patients with juvenile myoclonic epilepsy in Santa Catarina State, Brazil].
    Figueredo R; Trevisol-Bittencourt PC; Ferro JB
    Arq Neuropsiquiatr; 1999 Jun; 57(2B):401-4. PubMed ID: 10450346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy.
    Jannuzzi G; Cian P; Fattore C; Gatti G; Bartoli A; Monaco F; Perucca E
    Epilepsia; 2000 Feb; 41(2):222-30. PubMed ID: 10691121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group.
    Beydoun A; Sackellares JC; Shu V
    Neurology; 1997 Jan; 48(1):182-8. PubMed ID: 9008516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.